[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350259-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350259-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ldhc4-drives-lung-adenocarcinoma-progression-by-inducing-lactylation-of-rb1-at-lysine-900-to-disrupt-the-rb1e2f1-complex","LDHC4 drives lung adenocarcinoma progression by inducing lactylation of RB1 at lysine 900 to disrupt the RB1–E2F1 complex","","Lactate dehydrogenase C4 (LDHC4) shows aberrant expression in cancers and associates with poor prognosis, yet its role in lung adenocarcinoma (LUAD) beyond glycolysis is not defined. This study evaluates LDHC4’s involvement in protein lactylation, targeting the tumor suppressor RB1, and combines bioinformatic survival analyses, validation in 90 paired LUAD tissues, and mechanistic assays in A549 and PC-9 cells. Results link LDHC4-driven increased RB1 lactylation at lysine 900 to destabilization of the RB1–E2F1 complex, G1/S arrest, and reduced malignant phenotypes, suggesting therapeutic value for the LDHC4–RB1 lactylation axis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ldhc4-drives-lung-adenocarcinoma-progression-by-inducing-lactylation-of-rb1-at-lysine-900-to-disrupt-the-rb1e2f1-complex/350259/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ldhc4-drives-lung-adenocarcinoma-progression-by-inducing-lactylation-of-rb1-at-lysine-900-to-disrupt-the-rb1e2f1-complex/350259.png","ImageObject",300,407,{"name":42,"@type":43},"Bintang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does LDHC4 contribute to lung adenocarcinoma progression in this study?","Question",{"text":63,"@type":64},"LDHC4 promotes LUAD cell proliferation, migration, and invasion and supports tumor growth in a xenograft model by increasing global protein lactylation and specifically lactylating RB1.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What specific modification of RB1 is central to the proposed mechanism?",{"text":68,"@type":64},"The study identifies lactylation of RB1 at lysine 900 (RB1–K900lac) as a key event that disrupts the RB1–E2F1 tumor-suppressive complex.",{"name":70,"@type":61,"acceptedAnswer":71},"Why does RB1–K900 lactylation affect RB1–E2F1 binding?",{"text":72,"@type":64},"Lactylation at K900 is linked to increased structural fluctuation and weakened intermolecular interactions, destabilizing the RB1–E2F1 complex.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350259,1790193443,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Peng et al. Journal of Translational Medicine (2026) 24:653  \n[https://doi.org/10.1186/s12967-026-08070-9](https://doi.org/10.1186/s12967-026-08070-9)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nLDHC4 drives lung adenocarcinoma progression by inducing lactylation of RB1 at lysine 900 to disrupt the RB1–E2F1 complex  \nWei Peng1,2,3, Zhi Lin1,2,3, Cheng Sun1,2,3, Lingjing Lin 1,2,3, Zhaolei Cui1,2,3* and Donghong Lin 1,2*  \nAbstract  \nBackground The metabolic enzyme lactate dehydrogenase C4 (LDHC4) is aberrantly expressed in cancers and linked to poor prognosis. However, its role in lung adenocarcinoma (LUAD) and the molecular mechanisms beyond glycolysis remain unclear. This study investigates whether LDHC4 promotes LUAD by modulating protein lactylation, a lactate-derived post-translational modification, focusing on the tumor suppressor retinoblastoma protein (RB1) . Methods LDHC4 expression and its correlation with clinicopathological features and survival were analyzed using public databases (UALCAN, Kaplan-Meier Plotter, LOGpc) and validated in a cohort of 90 paired LUAD tissues via immunohistochemistry. The functional impact of LDHC4 on proliferation, migration, and invasion was assessed in A549 and PC-9 cells using gain-and loss-of-function models. The global lactylation profile was analyzed using DIAbased lactylation proteomics on the Astral platform. The interaction between RB1 and E2F1 (E2F transcription factor 1) was examined through molecular dynamics simulations, co-immunoprecipitation (Co-IP), and immunofluorescence. The functional consequences of site-specific RB1 lactylation at lysine 900 (RB1–K900lac) were determined using RB1– K900R mutant constructs and cell cycle analysis.  \nResults LDHC4 was significantly overexpressed in LUAD tissues, correlating with poor patient survival, and was an independent prognostic risk factor. In vitro, LDHC4 promoted LUAD cell proliferation, migration, and invasion, and its tumor-promoting role was corroborated in an LUAD xenograft model, in which derived tumors exhibited increased volume and weight compared with mock-transfected controls. Mechanistically, LDHC4 overexpression elevated global protein lactylation levels and specifically increased lactylation of RB1 . Bioinformatics and molecular dynamics simulations identified K900 as a key conserved residue for RB1–E2F1 binding; its lactylation destabilized the complex by increasing structural fluctuation and weakening intermolecular interactions. Cellular experiments confirmed that the lactylation-resistant RB1–K900R mutant bound E2F1 more strongly than wild-type RB1 . Functionally, cells expressing RB1–K900R exhibited suppressed malignant phenotypes and G1/S cell cycle arrest, accompanied by downregulation of CDKs/cyclins and upregulation of P21 .  \n*Correspondence: Zhaolei Cui [cuileidizi@fjmu.edu.cn](cuileidizi@fjmu.edu.cn)[ ](cuileidizi@fjmu.edu.cn)Donghong Lin [lindh65@fjmu.edu.cn](lindh65@fjmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright h","cbCaicTKreu7Jh5b","https://ap.wps.com/l/cbCaicTKreu7Jh5b","pdf",14577294,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Global context of lung cancer and LUAD\n## Metabolic reprogramming and lactate production\n## LDH isoenzymes and LDHC expression","[{\"question\":\"How does LDHC4 contribute to lung adenocarcinoma progression in this study?\",\"answer\":\"LDHC4 promotes LUAD cell proliferation, migration, and invasion and supports tumor growth in a xenograft model by increasing global protein lactylation and specifically lactylating RB1.\"},{\"question\":\"What specific modification of RB1 is central to the proposed mechanism?\",\"answer\":\"The study identifies lactylation of RB1 at lysine 900 (RB1–K900lac) as a key event that disrupts the RB1–E2F1 tumor-suppressive complex.\"},{\"question\":\"Why does RB1–K900 lactylation affect RB1–E2F1 binding?\",\"answer\":\"Lactylation at K900 is linked to increased structural fluctuation and weakened intermolecular interactions, destabilizing the RB1–E2F1 complex.\"}]","LDHC4 drives lung adenocarcinoma progression by inducing lactylation of RB1 at lysine 900 to disrupt the RB1–E2F1 complex | PDF",1790088126,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6426ec03a8d3a1f9a50b46208cfb3e04.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b9f1962efe8a60ce77fb4172ee92726.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6a105b5c8abc1d031dd499002d10389.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8b8ba8347a7e9ba49ce74a2ae5e2953.webp",980,1306]